Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 512-516

  Morton Jr , Ronald A ^a   Watkins, John J ^a   Bova, G Steven ^a   Wales, Michelle Makos ^a   Baylin, Stephen B ^a   Isaacs, William B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostatic neoplasms; prostatic hyperplasia; genes; Suppressor; Tumor

Indexed keywords

ARTICLE; CHROMOSOME 17; COMPARATIVE STUDY; HUMAN; MALE; METABOLISM; METHYLATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; MALE; METHYLATION; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0030211260     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)65916-0     Document Type: Article

References (29)

1. Jones, P. A.: DNA methylation and cancer. Cancer Res., 46: 461, 1986.
2. Baylin, S. B., Makos, M., Wu, J., Yen, R.-W. C., de Bustros, A., Vertino, P. and Nelkin, B. D.: Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383, 1991.
3. Larsen, F., Gundersen, G. and Prydz, H.: Choice of enzymes for mapping based on CpG islands in the human genome. Gene. Anal. Tech. Appl., 9: 80, 1992.
4. Larsen, F., Gundersen, G., Lopez, R. and Prydz, H.: CpG islands as gene markers in the human genome. Genomics, 13: 1095, 1992.
5. Migeon, B. R.: Insights into X chromosome inactivation from studies of species variation, DNA methylation and replication, and vice versa. Genet. Res., 56: 91, 1990.
6. Rainier, S. and Feinberg, A. P.: Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst., 86: 753, 1994.
7. Boyes, J. and Bird, A.: DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64: 1123, 1991.
8. Antequera, F., Boyes, J. and Bird, A.: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503, 1990.
9. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B. and Davidson, N. E.: Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552, 1994.
10. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M. and Baylin, S. B.: Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. U.S.A., 91: 9700, 1994.
11. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D. and Sakai, T.: CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8: 1063, 1993.
12. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B. and Baylin, S. B.: Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. U.S.A., 89: 1929, 1992.
13. Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J., Isaacs, W., Linehan, M. and Baylin, S. B.: Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53: 2719, 1993.
14. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K, Brodeur, G. M. and Baylin, S. B.: DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53: 2715, 1993.
15. Cappa, A. P., Callahan, R. and Liscia, D. S.: Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas. Cancer Genet. Cytogenet., 76: 106, 1994.
16. Nagai, M. A., Pacheco, M. M., Brentani, M. M., Marques, L. A., Brentani, R. R., Ponder, B. A. and Mulligan, L. M.: Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br. J. Cancer, 69: 754, 1994.
17. Wales, M. M., Biel, M. A., El Diery, W., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J. and Baylin, S. B.: p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nature Med., 1: 570, 1995.
18. Bova, G. S., Fox, W. M. and Epstein, J. I.: Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod. Pathol., 6: 201, 1993.
19. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I. and Isaacs, W. B.: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 87: 8751, 1990.
20. Ledbetter, S. A., Wallace, M. R., Collins, F. S. and Ledbetter, D. H.: Human chromosome 17 Notl linking clones and their use in long-range restriction mapping of the Miller-Dieker chromosome region (MDCR) in 17p13.3. Genomics, 7: 264, 1990.
21. Lothe, R. A., Nakamura, Y., Woodward, S., Gedde-Dahl, T., Jr. and White, R.: VNTR (variable number of tandem repeats) markers show loss of chromosome 17p sequences in human colorectal carcinomas. Cytogenet. Cell Genet., 48: 167, 1988.
22. Boring, C. C., Squires, T. S., Tong, T. and Montgomery, S.: Cancer Statistics: 1994. CA Cancer J. Clin., 44: 7, 1994.
23. Carter, H. B. and Coffey, D. S.: The prostate: an increasing medical problem. Prostate, 16: 39, 1990.
24. Coffey, D. S.: The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Campbell's Urology. Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughan, Jr. Philadelphia: William B. Saunders, vol. 1, chapt. 6, pp. 221-266, 1992.
25. Isaacs, W. B., Bova, G. S., Brooks, J. D., Ewing, C. M., Morton, R. A. and Robinson, J. R.: Genetic alterations in prostate cancer - prognostic implications? In: Prognostic Factors in Urological Cancers. Edited by J. Breul and R. Hartung., Port Washington, New York: Scholium International, Inc., pp. 84-92, 1993.
26. Shemer, R., Walsh, A., Eisenberg, S., Breslow, J. L. and Razin, A.: Tissue specific methylation patterns and expression of the human apolipoprotein AI gene. J. Biol. Chem., 265: 1010, 1990.
27. Shemer, R., Eisenberg, S., Breslow, J. L. and Razin, A.: Methylation patterns of the human apoA-I/C-III/A-IV gene cluster in adult and embryonic tissues suggest dynamic changes in methylation during development. J. Biol. Chem., 266: 23676, 1991.
28. Macoska, J. A., Micale, M. A., Sakr, W. A., Benson, P. D. and Wolman, S. R.: Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer, 8: 88, 1993.
29. Lee, W. H., Morton, R. A., Epstein, J. L, Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B. and Nelson, W. G.: Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. U.S.A., 91: 11733, 1994.